A new drug application for povorcitinib is expected to be filed in late 2025 to early 2026 to treat adult patients with ...

Researchers have found in a new study that patients with periodontal disease (PD) have significantly higher odds of ...

Abscess If you notice a painful bump on the roof of your mouth, it could be an abscess—an infection that forms when bacteria ...

Topline data were announced from pivotal phase 3 studies evaluating povorcitinib in adults with moderate to severe hidradenitis suppurativa.

Recognize early signs of dental problems like sensitivity, bleeding gums, and jaw pain to prevent serious oral health issues.

Incyte has delivered a pair of pivotal wins for an oral JAK inhibitor in an inflammatory skin condition. But with the placebo ...

On Monday, Incyte Corporation (NASDAQ:INCY) released topline results from its pivotal Phase 3 STOP-HS clinical trial program ...

Incyte Announces Positive Topline Results From Two Phase 3 Clinical Trials of Povorcitinib in Patients with Hidradenitis ...

Find out more about life changing charity dental work in Kuala Lumpur, Malaysia, carried about by the team at Treeline Dental ...

Less than two years removed from a brush with death that brought one of the lowest of lows, Easton Fothergill now stands atop ...

an oral Janus kinase 1 selective inhibitor, in adults 18 years and older with moderate to severe HS. To be enrolled in the studies, patients had to have a total abscess and inflammatory nodule (AN ...

Questions the vet will ask: The vet will usually remove some cells from the lump with a fine needle in order to examine them ...